tiprankstipranks
Trending News
More News >
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
India Market

Marksans Pharma Limited (MARKSANS) Financial Statements

Compare
2 Followers

Marksans Pharma Limited Financial Overview

Marksans Pharma Limited's market cap is currently ₹113.47B. The company's EPS TTM is ₹2.1; its P/E ratio is 29.81; and it has a dividend yield of 0.24%. Marksans Pharma Limited is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 26.23B₹ 21.77B₹ 18.52B₹ 14.80B₹ 13.68B
Gross Profit₹ 14.79B₹ 10.83B₹ 9.31B₹ 7.32B₹ 7.50B
Operating Income₹ 11.29B₹ 7.79B₹ 2.88B₹ 2.14B₹ 3.09B
EBITDA₹ 5.29B₹ 5.09B₹ 3.99B₹ 3.01B₹ 3.46B
Net Income₹ 3.81B₹ 3.14B₹ 2.66B₹ 1.85B₹ 2.39B
Balance Sheet
Cash & Short-Term Investments₹ 7.05B₹ 7.00B₹ 7.19B₹ 3.47B₹ 2.09B
Total Assets₹ 32.40B₹ 26.81B₹ 21.90B₹ 16.40B₹ 12.28B
Total Debt₹ 3.22B₹ 2.44B₹ 1.23B₹ 1.11B₹ 341.02M
Net Debt₹ -3.82B₹ -1.59B₹ -2.59B₹ -2.35B₹ -1.75B
Total Liabilities₹ 7.50B₹ 5.95B₹ 4.25B₹ 4.17B₹ 3.23B
Stockholders' Equity₹ 24.67B₹ 20.65B₹ 17.45B₹ 12.02B₹ 8.86B
Cash Flow
Free Cash Flow₹ 337.45M₹ 215.69M₹ 1.84B₹ 529.27M₹ 1.32B
Operating Cash Flow₹ 2.07B₹ 2.30B₹ 2.37B₹ 992.57M₹ 1.79B
Investing Cash Flow₹ -490.09M₹ -1.41B₹ -2.59B₹ -416.86M₹ -448.96M
Financing Cash Flow₹ -651.46M₹ -687.27M₹ 1.98B₹ 795.11M₹ -152.86M
Currency in INR

Marksans Pharma Limited Earnings and Revenue History

Marksans Pharma Limited Debt to Assets

Marksans Pharma Limited Cash Flow

Marksans Pharma Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis